Showing results (291-300 of 302) with videos related to

Sort By:
Pageof 31
Haematologica|October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-RBrian Hess, Alison Moskowitz, James A Davis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyTania Jain, Merav Bar, Ankit J Kansagra, et al.
JAMA Network Open|April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T TherapyJames P Long, Rishab Prakash, Paul Edelkamp, et al.
British Journal of Haematology|January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysisPaolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
The New England Journal of Medicine|December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
Nature Reviews. Clinical Oncology|February 20, 2021
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancerDristhi Ragoonanan, Sajad J Khazal, Hisham Abdel-Azim, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8+ T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Pageof 31